Tendinopathies are generally referred to as conditions including chronic pain and rupture in tendons. Since inflammatory cells are usually absent in the lesion, tendinopathy has long been recognised as a degenerative condition. Accordingly, anti-inf...

Giant cell arteritis (GCA), also known as temporal arteritis is a chronic inflammatory vasculitis that predominately affects large- and medium-sized arteries in individuals above the age of 50. More notably, GCA affects the cranial branches of the c...

Rheumatoid arthritis (RA) is a chronic inflammatory disease that can create joint damage and bone destruction, causing severe pain and disability. The disease also manifests as extra-articular disease, that can affect most organs of the body, with a...

Consensus Recommendations on COVID-19 Vaccination in Adult Patients with Autoimmune Rheumatic Diseases by the HKSR Clinical opinions generally advocate that COVID-19 vaccination is a critical measure to contain the current pandemic. Notably, patient...

A Great Leap forward in Therapeutic Development Discoveries of molecular mechanisms of different diseases provide unprecedented opportunities to develop novel medicines. However, the research and development of a brand-new drug is time-consuming and...

The Establishment of Consensus Statements on Management of Systemic Lupus Erythematosus for Asia-Pacific Region Systemic lupus erythematosus (SLE) is a multi-systemic autoimmune disease characterised by periods of exacerbation and remission, with or...

Adult patients with active ankylosing spondylitis (AS) treated with intravenously (IV) administered an anti-tumor necrosis factor (anti-TNF) monoclonal antibody, golimumab (GOL), demonstrated improvements in sleep problems, total back pain (TBP) and...

Biologic or targeted synthetic disease modifying anti-rheumatic drugs (DMARDs) are well-known for increasing the risk of serious infections (SI). Few studies conducted in real-world setting directly compared the incidence rate (IR) of serious bacter...

Real Life 12 Year Retention Rate of Subcutaneous Anti-TNF in Spondyloarthritis. Results from a Multicenter Cohort of 1170 Patients By Dr. Andus Ng Spondyloarthritis (SpA) patients starting golimumab (GOL) have the best drug retention compared to tho...

Risk Prediction and Preconception Counselling on Adverse Pregnancy Outcomes in Systemic Lupus Erythematosus Pregnancy is challenging for both women with systemic lupus erythematosus (SLE) and their treating physicians as it is associated with an inc...